0
Reprogrammed NK immune cells target cancer and autoimmune disorders
MIT News | Massachusetts Institute of Technology
Reprogrammed NK immune cells target cancer and autoimmune disorders
MIT engineers developed lipid nanoparticles that deliver mRNA to program natural killer (NK) cells inside the body. These CAR NK cells could be used to treat T cell cancers or autoimmune disorders caused by autoreactive T cells.
news.mit.edu
0 comments
log in to comment.